GCG Group
HomeNewsSustainable Pharmaceutical Ingredients: How to Switch
Sustainable Pharmaceutical Ingredients: How to Switch
Sustainability 18. 7. 2026 Redakce GCG Chemicals

Sustainable Pharmaceutical Ingredients: How to Switch

How to replace traditional pharmaceutical ingredients with eco-friendly alternatives without compromising quality? Practical tips for manufacturers.

Sustainable Pharmaceutical Raw Materials: How to Switch to Greener Alternatives Without Compromising Quality

Photo: Egor Myznik / Unsplash

The pharmaceutical industry is one of the sectors with high demands for quality, purity, and stability of raw materials. At the same time, however, it faces increasing pressure to reduce its environmental footprint—whether due to legislative requirements, investor pressure, or patient demand. Transitioning to more sustainable alternatives is not straightforward: comparable efficacy, biocompatibility, and long-term stability must be ensured. What options are available today, and how can they be implemented into production processes without risking the final product? This article focuses on specific examples of green alternatives, their advantages and challenges, and how to verify their suitability for particular applications.

Why Sustainability in Pharmaceutical Raw Materials is Key

The pharmaceutical industry is one of the sectors with high demands for quality, purity, and safety of raw materials. At the same time, however, it faces increasing pressure to reduce its environmental footprint—whether due to regulatory requirements, customer expectations, or long-term economic sustainability. Transitioning to greener alternatives is not just a matter of ecology but also a strategic advantage: companies that invest in sustainable raw materials often achieve lower waste disposal costs, better access to markets with strict environmental standards, and a stronger position in the supply chain.

A key factor is compatibility with current regulations, particularly REACH and CLP, which set limits for hazardous substances and their alternatives. Sustainable raw materials often also meet requirements for biodegradability, low toxicity, and minimization of volatile organic compound (VOC) emissions. For pharmaceutical manufacturers, this means the possibility of reducing contamination risks, simplifying cleaning and recycling processes, and thus lowering overall production costs. Green alternatives are therefore not just an ecological gesture but also a pragmatic step toward more efficient operations.

How to Identify Sustainable Alternatives Without Compromising Quality

When searching for greener raw materials, it is essential to assess their properties comprehensively—not only their ecological profile but also technical performance, stability, and compatibility with existing production processes. The first step is a life cycle assessment (LCA) of the raw material, which includes evaluating energy consumption, greenhouse gas emissions, and impacts on water and soil ecosystems. For example, vegetable oil-based polyols can offer comparable viscosity and reactivity to their petrochemical counterparts but with a significantly lower carbon footprint.

An important criterion is also the certification of raw materials according to recognized standards, such as eco-labels or confirmation of renewable origin. For pharmaceutical applications, it is essential to verify whether the alternative meets purity requirements, microbiological safety, and the absence of undesirable impurities. Laboratory tests should include stability, compatibility with other components, and reproducibility of results. Only in this way can it be ensured that the transition to a more sustainable raw material does not compromise the quality of the final product.

How to identify sustainable alternatives without compromising quality

Photo: Egor Myznik / Unsplash

Practical steps for implementing green raw materials in production

Transitioning to sustainable raw materials requires a systematic approach, starting with a thorough analysis of existing processes. The first step is mapping raw materials with the highest environmental impact – such as solvents with high VOC content or synthetic polymers with low biodegradability. This is followed by searching for alternatives with similar technical properties that can be integrated into production with minimal equipment modifications. It is advisable to begin with small-scale pilot tests to evaluate the impact on product quality and process efficiency.

Collaboration with suppliers who have experience with sustainable raw materials and can provide technical support plays a key role. For example, suppliers of sugar-based or plant-extract surfactants often offer detailed application data that facilitate the transition. Employee training is also important to ensure proper handling of new raw materials and the ability to identify any deviations in production. Gradual implementation and continuous evaluation of results minimize risks and enable a smooth transition to greener alternatives.

The Future of Pharmaceutical Raw Materials: Trends and Innovations

The development of sustainable raw materials for the pharmaceutical industry is moving in several directions, with the most significant trend being the use of renewable resources and biotechnologies. For example, fermentation processes enable the production of active substances from microorganisms or plant cells, reducing dependence on fossil resources. Another innovation is biodegradable polymer carriers for drugs, which decompose into harmless substances after fulfilling their function, eliminating waste issues.

Another promising direction is the circular economy, which emphasizes recycling and the reuse of raw materials. For example, solvents used in pharmaceutical production can be regenerated and reused, reducing the consumption of new raw materials and waste disposal costs. Digital technologies, such as artificial intelligence and machine learning, also play a significant role by helping to optimize production processes and predict the properties of new raw materials. These innovations not only improve the ecological profile of pharmaceutical products but also open up new possibilities for developing more effective and safer medicines.

The future of pharmaceutical raw materials: Trends and innovations

Photo: Egor Myznik / Unsplash

Optimizing the supply chain for sustainable pharmaceutical raw materials

Transitioning to sustainable pharmaceutical raw materials requires not only selecting more eco-friendly alternatives but also revising the entire supply chain. A key step is collaborating with suppliers who transparently document the origin of raw materials, their environmental footprint, and adherence to circular economy principles. For example, raw materials sourced from renewable resources, such as plant-based oils instead of petroleum derivatives, can significantly reduce the carbon footprint of production. It is also important to verify whether suppliers meet REACH and CLP requirements and whether their manufacturing processes minimize waste and energy consumption.

Another factor is local sourcing, which reduces emissions associated with transportation and supports the regional economy. However, for pharmaceutical raw materials, where quality and stability are critical, it is necessary to carefully evaluate the risks associated with changing suppliers. Standard testing methods must be used to verify whether new raw materials meet purity, stability, and efficacy requirements. Implementing digital tools for supply chain monitoring can help track compliance with sustainable practices in real time and quickly respond to any deviations.

Ecodesign of Pharmaceutical Formulations: How to Develop More Sustainable Products

Ecodesign in the field of pharmaceutical raw materials means developing products to minimize their negative environmental impact throughout their entire lifecycle. This includes selecting raw materials with lower toxicity, biodegradability, and recyclability. For example, replacing synthetic solvents with water or bio-based solvents can significantly reduce volatile organic compound (VOC) emissions. It is also important to consider the energy intensity of manufacturing processes and seek ways to reduce it, such as optimizing temperature regimes or utilizing renewable energy sources.

In ecodesign, it is crucial to focus on the efficiency and safety of the product. Sustainable raw materials must meet the same quality standards as their conventional counterparts, which requires thorough testing of stability, compatibility, and bioavailability. For example, in the case of surfactants used in pharmaceuticals, it is necessary to verify whether bio-based alternatives do not impair the solubility of active substances or their penetration into the organism. Collaboration with research laboratories and the use of advanced analytical methods help identify optimal combinations of raw materials that are environmentally friendly and effective in terms of therapeutic effect.

Regulatory and Certification Aspects of Sustainable Pharmaceutical Raw Materials

The implementation of sustainable raw materials in the pharmaceutical industry is closely linked to regulatory requirements that ensure the safety and efficacy of medicinal products. According to the REACH regulation, all chemical substances must be registered and assessed for health and environmental risks. Sustainable alternatives often undergo stricter evaluation, as their ecological benefits must be balanced with pharmaceutical quality. For example, bio-based raw materials may require additional stability tests to demonstrate that they do not affect the shelf life or efficacy of the medicinal product.

Certifications such as GMP (Good Manufacturing Practice) or ISO 14001 for environmental management are important tools that help manufacturers demonstrate compliance with sustainable practices. These certifications not only enhance credibility with customers but also facilitate access to markets with strict environmental standards. For pharmaceutical companies, it is advantageous to collaborate with suppliers who hold these certifications, as this reduces the risk of non-compliance with regulatory requirements. It is also important to monitor updates in legislation, such as new requirements for packaging recyclability or restrictions on the use of certain substances, to enable timely adaptation of manufacturing processes.

Need help selecting sustainable raw materials?

Each pharmaceutical raw material requires individual assessment in terms of stability, compatibility, and regulatory requirements. GCG Group provides detailed technical data sheets and safety data sheets (SDS) for every product, and our experts will help you select the optimal solution for your production – including sustainable alternatives. Contact us – or browse our catalog of over 1,300 products right away.

Inquiry Basket

0 products

Basket is empty

Add products from the catalog

Favorites

0 products

No favorite products yet

Click the heart icon on a product to save it here